News
MightySat Medical is powered by Masimo SET ® pulse oximetry, a hospital-grade technology that was previously cleared by the FDA. The OTC clearance was also supported by data from 39 healthy study ...
Masimo's (MASI) MightySat Medical Pulse Oximeter receives FDA clearance, which makes it the first FDA-approved pulse oximeter to be available OTC.
Earlier this week, Masimo announced the FDA clearance of the MightySat Fingertip Pulse Oximeter, representing the first FDA-cleared fingertip pulse oximeter for over-the-counter (OTC) sale directly to ...
Patients in the RPM cohort were discharged with a Masimo MightySat ® pulse oximeter and an Omron blood pressure monitor, provided by Masimo, which connected wirelessly to the Masimo SafetyNet app ...
In February, Masimo received the FDA’s clearance for MightySat Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available over-the-counter to consumers without ...
On Aug. 10, Masimo reported second-quarter sales rose 85% to $565.3 million. The sales boost was expected because of Masimo’s acquisition of Sound United, which was completed in April. The company ...
Masimo Reports First Quarter 2025 Results. Masimo Corporation (Nasdaq: ... Radius PPG ® and Radius VSM ™, portable devices like Rad-67 ®, fingertip pulse oximeters like MightySat ...
Oct 25 (Reuters) - Apple (AAPL.O), opens new tab convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's (MASI.O), opens new tab smartwatches infringe two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results